Council of Autism Service Providers Logo
Back to Events
Webinars

The Impact of Treatment Intensity on Outcomes for Young Children with Autism

Friday, April 25, 2025
3:00 PM - 4:00 PM (EDT)

Hosted on Zoom

Event Details

Abstract

This webinar will provide a detailed description of the CASP (2025) White Paper, "Evidence About ABA Treatment for Young Children with Autism: The Impact of Treatment Intensity on Outcomes."

This companion to the 3rd edition of CASP’s Applied Behavior Analysis Practice Guidelines for the Treatment of Autism Spectrum Disorder provides the generally accepted standards of care (GASC) for ABA services for young autistic children, an overview of the existing
literature on treatment intensity, new benchmark data for outcomes, guidance on how to evaluate new studies and meta-analyses, and commentary on two recently published studies.

We will describe how GASC are created and how they support practitioners in providing evidence-based care and engaging in advocacy work with caregivers, funders, and other stakeholders.

Learning Objectives

  1. Attendees will be able to identify characteristics of the process for creating GASC.
  2. Attendees will be able to identify how scope and intensity impact the effectiveness of behavioral treatment services.
  3. Attendees will be able to identify features of research studies that can limit the conclusions that can be drawn about the impact of treatment intensity.

This webinar offers 1.0 BACB Learning CEU.

Cost

  • CASP Members - free
  • non-members - $20

Presenters

Linda LeBlanc, PhD, BCBA-D, Lic Psy

Linda A. LeBlanc, Ph.D., BCBA-D, Licensed Psychologist is the President of LeBlanc Behavioral Consulting and the Executive Director of the Action Institute for Outcomes Research. She is the past Editor in Chief of the Journal of Applied Behavior Analysis, a Fellow of ABAI, and the 2016 recipient of the APA Nathan H. Azrin Award for Distinguished Contribution in Applied Behavior Analysis. Her professional interests include behavioral treatments and outcomes, supervision and mentoring, and ethics.
Jane Howard, PhD, BCBA-D, Lic Psy

Jane Howard, Ph.D., BCBA, is a Board-Certified Behavior Analyst (BCBA-D®). She is the Co- Founder of Therapeutic Pathways and Senior Advisor to Blue Sprig Pediatrics and Trumpet Behavioral Health. Dr. Howard is the lead author of several widely cited outcome studies regarding treatment outcomes for individuals with autism. She was a Founding Member of the Council of Autism Service Providers and is also a member of the Advisory Board for the National Autism Law Center. In addition, Dr. Howard is the Past President of the Board of Directors for the Behavior Analyst Certification Board. Dr. Howard is also a Professor Emeritus of Psychology at California State University, Stanislaus, where she spent decades training graduate students in behavior analysis and clinical psychology. In that capacity, she published multiple research papers examining various intervention strategies to support independence in individuals with developmental delays. Dr. Howard also established several university-affiliated community programs to improve access to services for individuals with learning disabilities and cognitive impairments. These various roles reflect Dr. Howard’s long-standing commitment and passion for developing the clinical infrastructures needed to support access to high-quality care by those who need services.